Figure 1

Figure 1

A single IV dose of ENTR-601-44 resulted in robust exon skipping in both skeletal and cardiac muscles in NHP, as well as prolonged duration of effect for at least 12 weeks

Format

JPEG

Source

Entrada Therapeutics, Inc.

Téléchargements